Directed evolution based on the crystal structure of PD-1/PD-L1 complex enabled to engineer the PD-1 ectodomain as a high-affinity (110 pM) competitive antagonist of PD-1 showing superior tumor penetration43. Here, CD274 is linked to neoplasm.